The hypothetical target trial would randomize adults with DM to either: GLP-1RA therapy or DPP-4i therapy (Cohort 1), or GLP-1RA therapy or SGLT-2i therapy (Cohort 2), with the goal of evaluating time to HSV or HZ infection (ICD-9-CM codes 054, 053
The fibrosis staging report is the single most commonly missing document make sure it's attached and easy to find
Phenylephrine promotes phosphorylation of Bad in cardiac myocytes through the extracellular signal-regulated kinases 1/2 and protein kinase A
Ketamine and psilocybin each produce a brief acute experience but set off a wave of synaptic growth afterward, ketamine through glutamate release and mTOR-dependent synapse formation and psilocybin through rapid, lasting growth of dendritic spines in the frontal cortex, both via BDNF signaling, which is why a single session can shift symptoms for weeks
What the trials measured Roughly 1015% weight loss in obesity arms by week 24
Semaglutide is a GLP-1 receptor agonist, which means it works by affecting certain hormones in the body